Biotech News

Corcept Presents New Data At Asco 2026 Lifyorli Overall Survival Across All Subgroups Of Patients With Platinum Resistant Ovarian Cancer Including Those With Recent Taxane Exposure

CORT (CORT)cort.com2026-04-10 09:30 ESTCompany update

CORT (CORT) appears in the live feed after a catalyst-style update. The headline is surfaced in real time so readers can move from signal to source without leaving the product flow.

The source domain is cort.com. BioPharmSignal keeps the ticker, timestamp, and source together for faster review before the wider market catches up.

The original release is available below in a new tab so readers can continue into the full source when needed.

Open original release

Related news

No closely related headlines were available from the latest feed snapshot.

View all latest news

Corcept

Corcept is a biopharmaceutical company focused on advancing a pipeline of therapeutic programs. Investors usually track how clinical data, regulatory milestones, and launch execution change the story over time.

Recent company news

CORTCorcept2026-05-29 16:37:34 EST